Search - tctmd.com

Displaying 1 - 20 of 36

Sort: Relevancy | Date

News Conference News TCT 2018

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

Todd Neale

September 26, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

Shelley Wood

September 25, 2018

Presentation TCT 2018

RADIOSOUND-HTN: A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension

Presenter: Felix Mahfoud, Patrick W. Serruys, Philipp Lurz

September 25, 2018

News Conference News TCT 2018

Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation

Todd Neale

September 25, 2018

Presentation TCT 2018

Pacemaker Mediated Hypertension Treatment (BackBeat): First-in-Man Results and Ongoing Plans

Presenter: Mark C. Bates, Farrell O. Mendelsohn, Daniel Burkhoff

September 24, 2018

Presentation TCT 2018

AV-Fistula Creation (ROX Coupler): Efficacy and Safety Results

Presenter: Mark C. Bates, Farrell O. Mendelsohn, Krishna J. Rocha-Singh

September 24, 2018

Presentation TCT 2018

Transcatheter Carotid Body Denervation (Cibiem): Extended Follow-Up and Future Directions

Presenter: Mark C. Bates, Farrell O. Mendelsohn, Felix Mahfoud

September 24, 2018

Carotid Body Endovascular Baroreflex Amplification (Vascular Dynamics MobiusHD): Current Status

Presentation TCT 2018

Carotid Sinus Endovascular Baroreflex Amplification (Vascular Dynamics MobiusHD): Current Status

Presenter: Mark C. Bates, Farrell O. Mendelsohn, Gregg W. Stone

September 24, 2018

Presentation TCT 2018

Targets for Device-Based Hypertension Treatments Beyond the Kidneys: Physiology Revisited

Presenter: Mark C. Bates, Farrell O. Mendelsohn

September 24, 2018

Presentation TCT 2018

Sensing Renal Nerve Activity Before, During, and After Denervation: SyMap

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, Jie Wang

September 24, 2018

Presentation TCT 2018

Sensing Renal Nerve Activity Before, During, and After Denervation: Autonomix

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, Robert S. Schwartz

September 24, 2018

Presentation TCT 2018

Predicting Responders vs Non-Responders How to Solve the Unmet Need?

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, Justin E. Davies

September 24, 2018

Presentation TCT 2018

Who are the Ideal Candidates for Renal Denervation?

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, Andrew Sharp

September 24, 2018

Presentation TCT 2018

Clinical Trials All Look Positive: Is Renal Denervation Ready for Clinical Practice Now?

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, Chandan Devireddy

September 24, 2018

Presentation TCT 2018

Alcohol-Mediated Renal Denervation Current Status and US Pivotal Trial Plans

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh

September 24, 2018

Presentation TCT 2018

Results and Update From the Vessix RE-INFORCE Program

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, Martin B. Leon

September 24, 2018

Presentation TCT 2018

Results and Update From the Paradise Hypertension Program (OFF-MED and ON-MED Studies)

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, Ajay J. Kirtane

September 24, 2018

Presentation TCT 2018

Results and Update From the SPYRAL Hypertension Program (OFF-MED and ON-MED Trials)

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, David E. Kandzari

September 24, 2018

Presentation TCT 2018

Device Therapy Offers a Viable Alternative to Medical Therapy, and Should Be Considered as a Reasonable Alternative!

Presenter: Joost Daemen

September 24, 2018

Presentation TCT 2018

Drugs Work and Should Always Be Used as First-Line Therapy!

Presenter: Melvin D. Lobo

September 24, 2018

Advertisement

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

RADIOSOUND-HTN: A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension

Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation

Pacemaker Mediated Hypertension Treatment (BackBeat): First-in-Man Results and Ongoing Plans

AV-Fistula Creation (ROX Coupler): Efficacy and Safety Results

Transcatheter Carotid Body Denervation (Cibiem): Extended Follow-Up and Future Directions

Carotid Sinus Endovascular Baroreflex Amplification (Vascular Dynamics MobiusHD): Current Status

Targets for Device-Based Hypertension Treatments Beyond the Kidneys: Physiology Revisited

Sensing Renal Nerve Activity Before, During, and After Denervation: SyMap

Sensing Renal Nerve Activity Before, During, and After Denervation: Autonomix

Predicting Responders vs Non-Responders How to Solve the Unmet Need?

Who are the Ideal Candidates for Renal Denervation?

Clinical Trials All Look Positive: Is Renal Denervation Ready for Clinical Practice Now?

Alcohol-Mediated Renal Denervation Current Status and US Pivotal Trial Plans

Results and Update From the Vessix RE-INFORCE Program

Results and Update From the Paradise Hypertension Program (OFF-MED and ON-MED Studies)

Results and Update From the SPYRAL Hypertension Program (OFF-MED and ON-MED Trials)

Device Therapy Offers a Viable Alternative to Medical Therapy, and Should Be Considered as a Reasonable Alternative!

Drugs Work and Should Always Be Used as First-Line Therapy!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content